Oklahoma City, OKNCT05565417Now EnrollingIRB Ready

Cancer Clinical Trial in Oklahoma City, OK

Access cutting-edge cancer treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.

Sponsored by Immunitas Therapeutics

Quick Self-Assessment

See if you qualify for this Oklahoma City location

Preparing your pre-screening questions...

Expert Care in Oklahoma City

Access cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cancer treatment provided free

Apply for This Oklahoma City Location

Check if you qualify for this cancer clinical trial in Oklahoma City, OK

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Oklahoma City

    Convenient for OK residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Oklahoma City site if eligible
  4. 4Begin participation

About This Cancer Study in Oklahoma City

This is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with solid tumors or lymphomas. The main goals of this study are to: * Find the recommended dose of IMT-009 that can be safely given to participants * Learn more about the side effects of IMT-009 * Learn more about pharmacokinetics of IMT-009 * Learn more about the effectiveness of IMT-009 * Learn more about different pharmac

Sponsor: Immunitas Therapeutics

Who Can Participate

Inclusion Criteria

Phase 1: 1. Males and females ≥18 years of age at the time of consent 2. Willingness and capacity to provide written consent 3. Patients who have histologically or cytologically-documented, unresectable locally advanced, or metastatic solid malignancy or designated lymphoma that is progressing or has failed the therapies listed below or who are intolerant of or are ineligible for or refuse standard of care therapy as detailed below.
Patients previously pre-treated with a checkpoint inhibitor must be anti-PD-L1 relapsed/refractory defined as having clear evidence of radiologic or clinical progression while on or within 4 months of their last anti-PD-L1 dose.
There is no limit to the number of prior treatment regimens a patient may have had prior to enrollment. Has one of the following solid tumor or lymphoma indications:
Non-small cell lung cancer (NSCLC) - squamous or non-squamous:
Must have received prior chemotherapy and a checkpo

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Oklahoma City?

Yes, this clinical trial (NCT05565417) has an active research site in Oklahoma City, OK that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cancer Treatment Options in Oklahoma City, OK

If you're searching for cancer treatment options in Oklahoma City, OK, this clinical trial (NCT05565417) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Oklahoma City, OK

See all breast cancer clinical trials recruiting in Oklahoma City — not just this study.

Browse Breast Cancer Trials in Oklahoma City →

Browse More Trials by Condition

Breast Cancer TrialsLung Cancer TrialsProstate Cancer TrialsColorectal Cancer TrialsMelanoma TrialsPancreatic Cancer TrialsOvarian Cancer TrialsBladder Cancer TrialsAll Conditions →

Ready to Join in Oklahoma City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Oklahoma City, OK